Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Curve type (GR values) Curve type (relative cell counts) Experiment name Number of concentrations Cell doublings (DMSO control) GR50 GRmax GR_AOC GEC50 GRinf Hill slope (GR values) R-squared sigmoid fit (GR values) P-value sigmoid fit (GR values) R-squared flat fit (GR values) IC50 Emax AUC EC50 Einf Hill slope (relative cell counts) R-squared sigmoid fit (relative cell counts) P-value sigmoid fit (relative cell counts) R-squared flat fit (relative cell counts)
HCC1806 Torin2 3 72
sigmoid
sigmoid
HCC1806 Torin2 0 3 72
8 3.212
0.0678
-0.0927
0.522
0.0798
-0.12
1.32
0.996
6.56e-08
NA
0.0486
0.079
0.492
0.0442
0.0528
1.17
0.995
1.09e-07
NA
HCC1806 Omipalisib 3 72
sigmoid
sigmoid
HCC1806 omipalisib 0 3 72
8 3.217
0.147
-0.221
0.437
0.71
-0.707
0.559
0.981
7.41e-06
NA
0.0642
0.0481
0.54
0.0538
0.0749
0.919
0.979
9.93e-06
NA
HCC1806 Alpelisib 3 72
flat
flat
HCC1806 alpelisib 0 3 72
8 3.224
Inf
0.93
0.0502
0.0
0.93
0.01
-0.335
1.0
0.948
Inf
0.891
0.921
0.0
0.891
0.01
-0.351
1.0
0.919
HCC1806 Pictilisib 3 72
sigmoid
sigmoid
HCC1806 pictilisib 0 3 72
8 3.234
14.1
0.818
0.0423
52.2
-0.98
0.831
0.814
0.00649
NA
11.3
0.734
0.935
11.3
0.0
0.849
0.773
0.0116
NA
HCC1806 Everolimus 3 72
sigmoid
sigmoid
HCC1806 everolimus 0 3 72
8 3.239
Inf
0.813
0.159
0.000271
0.812
0.356
0.879
0.00175
NA
Inf
0.727
0.765
0.00022
0.729
0.377
0.879
0.00177
NA
HCC1806 WYE-125132 3 72
sigmoid
sigmoid
HCC1806 WYE-132 0 3 72
8 3.242
Inf
0.531
0.255
0.0458
0.517
0.885
0.997
3.48e-08
NA
0.226
0.42
0.663
0.0335
0.402
0.855
0.996
8.79e-08
NA
HCC1806 Sirolimus 3 72
sigmoid
sigmoid
HCC1806 rapamycin 0 3 72
8 3.249
0.223
0.805
0.162
0.000183
0.746
0.1
0.663
0.0382
NA
1.05
0.717
0.76
1e-05
0.657
0.1
0.68
0.0328
NA